Sort
261,768 grants matching “gene therapy”
Predicting pancreatic cancer responses for a Parp inhibitor-based clinical trial
$962,168Michael G. Goggins · Johns Hopkins University · RC2 · FY2010 · CA
Determinants of Individual Differences in the Efficacy of Aerobic Exercise to Improve Brain Health and Reduce Alzheimer Disease Risk in Older African Americans
$962,143Mark A Gluck · Rutgers The State Univ Of Nj Newark · R01 · FY2024 · AG
Inflammation and Fibrosis in Pulmonary TB: the INFIN-TB Study
$962,133Sara Auld · Emory University · R01 · FY2022 · AI
Novel Targets for Vaccine Therapy
$962,130Claudia Palena · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA
Cancer Etiology, Prevention, Detection and Diagnosis
$961,992Amato J. Giaccia · Stanford University · T32 · FY2008 · CA
Nonhuman Primate Core
$961,891Hans-Peter Kiem · University Of California Los Angeles · U19 · FY2023 · AI
P1 - COMBINATION ACTIVATED T-CELL AND VACCINE THERAPY IN MYELOMA
$961,866Larry W Kwak · University Of Tx Md Anderson Can Ctr · P50 · FY2013 · CA
Bio-Therapies for the Treatment of Cancer and Infectious Disease
$961,795David Fitzgerald · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Combination Immunotherapy of a Novel Superagonist IL-15 Complex and Anti-CD20 Antibody for Indolent Non-Hodgkin Lymphoma
$961,768Hing C. Wong · Altor Bioscience. Llc · R44 · FY2015 · CA
Production of antibody therapeutic fragments by reduced genome E. coli in continuous culture
$961,744Frederick R Blattner · Scarab Genomics, Llc · R44 · FY2022 · AI
Metabolic Regulators of Tumor Growth and Progression
$961,705Ralph J Deberardinis · Ut Southwestern Medical Center · R35 · FY2017 · CA
Age-Related Macular Degeneration: Genetic Variations and Animal Model
$961,613Chi-Chao Chan · National Eye Institute · ZIA · FY2009 · EY
Achieving Tolerance to Cardiac Allografts using Vascularized Donor Thymus
$961,500Joren C Madsen · Massachusetts General Hospital · U01 · FY2015 · AI
Tolerance Strategies in Non-Human Primate Cardiac Allograft Recipients
$961,500Joren C Madsen · Massachusetts General Hospital · U01 · FY2015 · AI
Whole genome sequencing consortium on Frontotemporal dementia with underlying TDP-43 pathology
$961,469Rosa Rademakers · Mayo Clinic Jacksonville · UG3 · FY2017 · NS
Development of Akt Inhibitors
$961,463Phillip A. Dennis · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Signal Transduction Pathways that Promote Survival of Lung Cancer Cells
$961,463Phillip A. Dennis · Division Of Clinical Sciences - Nci · ZIA · FY2011 · CA
Image-guided dosimetry-based alpha particle therapy for neuroblastoma.
$961,450Michael King Schultz · Viewpoint Molecular Targeting, Inc. · R44 · FY2023 · CA
Center of Excellence for Health Disparities Research: EI Centro
$961,216Victoria B Mitrani · University Of Miami Coral Gables · P60 · FY2014 · MD
CTRIP: Genetic Testing to Individualize Management of Common Heart Diseases
$961,148Gerald W. Dorn · Washington University · RC2 · FY2009 · HL
INvestigations In Gout, Hyperuricemia, and comorbidiTies (INSIGHT) Center of Research Translation (CORT)
$961,116Kenneth G Saag · University Of Alabama At Birmingham · P50 · FY2019 · AR
Treatment of Glioblastoma: the combination of fluorescence guided surgery and photodynamic therapy
$960,821William R Potter · Photolitec, Llc · R44 · FY2022 · CA
Pharmacogenomics of ART adherence and effectiveness in the ALIVE Cohort
$960,711Brion S Maher · Johns Hopkins University · R01 · FY2020 · DA
Effect of opioid use disorder on HIV latent reservoirs and immune dysfunction assessed by single-cell transcriptomics
$960,627Christine Cheng · Boston University (Charles River Campus) · R61 · FY2019 · DA
Timing of Rectal Cancer Response to Chemoradiation
$960,599Julio Garcia-Aguilar · Beckman Research Institute/City Of Hope · R01 · FY2008 · CA